These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 34916741)

  • 1. Tofacitinib Associated with Reduced Intubation Rates in the Management of Severe COVID-19 Pneumonia: A Preliminary Experience.
    Singh PK; Lalwani LK; Govindagoudar MB; Aggarwal R; Chaudhry D; Kumar P; Gehlaut P
    Indian J Crit Care Med; 2021 Oct; 25(10):1108-1112. PubMed ID: 34916741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing of Invasive Mechanical Ventilation and Mortality among Patients with Severe COVID-19-associated Acute Respiratory Distress Syndrome.
    Zirpe KG; Tiwari AM; Gurav SK; Deshmukh AM; Suryawanshi PB; Wankhede PP; Kapse US; Bhoyar AP; Khan AZ; Malhotra RV; Kusalkar PH; Chavan KJ; Naik SA; Bhalke RB; Bhosale NN; Makhija SV; Kuchimanchi VN; Jadhav AS; Deshmukh KR; Kulkarni GS
    Indian J Crit Care Med; 2021 May; 25(5):493-498. PubMed ID: 34177166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Tofacitinib in the Management of COVID-19 Pneumonia.
    Bande BD
    Indian J Crit Care Med; 2021 Oct; 25(10):1089-1090. PubMed ID: 34916738
    [No Abstract]   [Full Text] [Related]  

  • 5. A 30-day Survival and Safety of Percutaneous Tracheostomy in Moderate-to-severe COVID-19 Pneumonia Patients: A Single-center Experience.
    Shah M; Bhatuka N; Shalia K; Patel M
    Indian J Crit Care Med; 2022 Oct; 26(10):1120-1125. PubMed ID: 36876194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Remdesivir Administration on Occurrence of Major Adverse Cardiac Events in Critically Ill COVID-19 Pneumonia: A Retrospective Observational Study.
    Panda R; Singh P; Jain G; Saigal S; Karna ST; Anand A; Kodamanchili S; Brahmam D; Jha S; Shivhare A
    Indian J Crit Care Med; 2022 Sep; 26(9):993-999. PubMed ID: 36213699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19: Winter is COMING!
    Chaudhry D; Kumar P; Singh PK; Govindagoudar MB
    Indian J Crit Care Med; 2020 Nov; 24(Suppl 5):S223-S224. PubMed ID: 33354046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination With Dexamethasone is Safe and Possibly Superior to Dexamethasone as a Single Agent in a Predominantly African American Cohort.
    Hayek ME; Mansour M; Ndetan H; Burkes Q; Corkern R; Dulli A; Hayek R; Parvez K; Singh S
    Mayo Clin Proc Innov Qual Outcomes; 2021 Jun; 5(3):605-613. PubMed ID: 33817559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Evaluation of Efficacy and Safety of Tofacitinib, A JAK Inhibitor in the Management of Hospitalized Patients with Mild to Moderate COVID-19 - An Open-Label Randomized Controlled Study.
    Murugesan H; Cs G; Nasreen HS; Santhanam S; M G; Ravi S; Es SS
    J Assoc Physicians India; 2022 Dec; 69(12):11-12. PubMed ID: 35057599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Intubation Timing on the Outcome of Patients With Severe Respiratory Distress Secondary to COVID-19 Pneumonia.
    Fayed M; Patel N; Yeldo N; Nowak K; Penning DH; Vasconcelos Torres F; Natour AK; Chhina A
    Cureus; 2021 Nov; 13(11):e19620. PubMed ID: 34804753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pilot and Feasibility Study to Evaluate the Effectiveness of Tofacitinib Add-On Therapy to Remdesivir in Severely Ill COVID-19 Patients.
    Dargahi-Malamir M; Hosseinzadeh M; Khedri R; Hosseininejad H; Behmanesh B; Hatami A; Oskouei SY; Mehraban Z; Kouti W; Pouladzadeh M
    Maedica (Bucur); 2024 Jun; 19(2):322-329. PubMed ID: 39188838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified Barrier Enclosure for Noninvasive Respiratory Support in COVID-19 Outbreak.
    Kumar P; Chaudhry D; Lalwani LK; Singh PK
    Indian J Crit Care Med; 2020 Sep; 24(9):835-837. PubMed ID: 33132569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awake Prone Positioning in COVID-19 Patients.
    Singh P; Jain P; Deewan H
    Indian J Crit Care Med; 2020 Oct; 24(10):914-918. PubMed ID: 33281314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helmet NIV in Acute Hypoxemic Respiratory Failure due to COVID-19: Change in PaO
    Jha OK; Kumar S; Mehra S; Sircar M; Gupta R
    Indian J Crit Care Med; 2021 Oct; 25(10):1137-1146. PubMed ID: 34916746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicoepidemiological Features and Mortality Analysis of Deceased Patients with COVID-19 in a Tertiary Care Center.
    Aggarwal R; Bhatia R; Kulshrestha K; Soni KD; Viswanath R; Singh AK; Iyer KV; Khanna P; Bhattacharjee S; Patel N; Aravindan A; Gupta A; Singh Y; Ganesh V; Kumar R; Ayub A; Kumar S; Prakash K; Venkateswaran V; Bhoi D; Soneja M; Mathur P; Malhotra R; Wig N; Guleria R; Trikha A
    Indian J Crit Care Med; 2021 Jun; 25(6):622-628. PubMed ID: 34316140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tofacitinib in Patients Hospitalized With Moderate and Severe COVID-19: Not Just Another Kinase Inhibitor.
    Shankar T; Rao A; S D; Hegde TS; Sundaresh S; Sahni T; Nagaraj SM
    Cureus; 2024 Jan; 16(1):e52725. PubMed ID: 38384612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tocilizumab and COVID-19.
    Chaudhry D; Singh PK
    Indian J Crit Care Med; 2020 Sep; 24(9):741-743. PubMed ID: 33132549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baricitinib and tofacitinib in patients with rheumatoid arthritis: results of regular clinical practice.
    González-Freire L; Giménez-Candela RM; Castro-Luaces S; Veiga-Villaverde AB; Crespo-Diz C
    Farm Hosp; 2021 Jun; 45(4):165-169. PubMed ID: 34218760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.